Salvage radiotherapy boosts disease-free survival in prostate cancer patients

June 23, 2008 Salvage radiotherapy boosts disease-free survival in prostate cancer patients Shalmali Pal -------------------------------------------------------------------------------- Treatment inside a two-year window and a prostate-specific antigen doubling time of less than six months may be the key factors in optimizing salvage radiotherapy results for recurrent prostate cancer, according to investigators from the Brady Urological Institute at Johns Hopkins School of Medicine. Their preliminary results offer evidence that salvage radiotherapy can improve prostate cancer-specific survival after radical prostatectomy.

See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC